Wealthspire Advisors (Maryland)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-538	Closed	-$50K	–	516
2019 Q1	$50K	Buy	538 +447	+491%	+$37.4K	﹤0.01%	890
2018 Q4	$7K	Buy	91 +2	+2%	+$154	﹤0.01%	1585
2018 Q3	$8K	Buy	89 +18	+25%	+$1.81K	﹤0.01%	1589
2018 Q2	$7K	Sell	71 -19	-21%	-$1.89K	﹤0.01%	1647
2018 Q1	$11K	Buy	90 +22	+32%	+$2.84K	﹤0.01%	1513
2017 Q4	$9K	Buy	68 +46	+209%	+$5.78K	﹤0.01%	1615
2017 Q3	$3K	Buy	22 +3	+16%	+$256	﹤0.01%	1891
2017 Q2	$2K	Buy	19 +7	+58%	+$447	﹤0.01%	1960
2017 Q1	$1K	Buy	+12	New	+$555	﹤0.01%	1762
2016 Q2	–	Sell	-6	Closed	–	–	1683
2016 Q1	$0	Sell	6 -3	-33%	-$199	﹤0.01%	1736
2015 Q4	$1K	Buy	+9	New	+$834	﹤0.01%	1588